South Korea: Agricultural Biotechnology Annual

  |   Attaché Report (GAIN)   |   KS2021-0025

Korea is in the process of revising its existing Living Modified Organism (LMO) Act to cover products of innovative biotechnologies, including genome edited products. The draft revision announced in May 2021 includes a pre-review process that will determine if certain products of innovative biotechnologies require a full risk assessment or can be exempt from evaluation. Despite objections from local non-governmental organizations (NGOs), Korea plans to complete its LMO revision process by the end of 2021. In April 2021, Korea identified 10 companies to promote green-bio convergence and invested 2.8 billion Korean won to support this initiative. Items developed by the selected companies include agricultural varieties that utilize genome editing technologies.

Related Reports

The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with European Union regulations.
Attaché Report (GAIN)

Tunisia: Agricultural Biotechnology Annual

Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.
Attaché Report (GAIN)

Thailand: Rice Price - Weekly

Export prices of white and parboiled rice rose one percent from the previous week as exporters reportedly continued to secure the rice supplies to fulfill contract shipments.